比较不可比较者:COVID-19肺炎与高原病
本文质疑部分临床医生认为COVID-19肺炎与高原性肺水肿临床特征相似的观点,指出两者本质不同,强调澄清误解以避免错误治疗策略。
要点
- COVID-19肺炎是病毒感染,高原性肺水肿是非心源性水肿,两者本质不同。
- 临床特征相似的观点缺乏依据,需警惕社交媒体放大错误理论。
- 澄清误解对避免错误治疗策略至关重要。
核心结论
- COVID-19肺炎与高原性肺水肿本质不同,不应将两者临床特征混为一谈。
临床怎么用
- 临床医生应避免基于两者相似性的错误理论制定治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
COVID-19 pneumonia is a viral infection; high-altitude pulmonary oedema is a non-cardiogenic oedema. Some clinicians have found the clinical features similar. It is important to clarify such misconceptions to prevent erroneous treatment strategies https://bit.ly/2KOBi3F The coronavirus disease 2019 (COVID-19) pandemic is overwhelming healthcare systems worldwide. There is no evidence from randomised clinical trials that any potential therapy improves outcome in COVID-19 pneumonia, and therapeutic strategies have been based on a progressively increasing knowledge of the clinical presentation of the disease. Some clinicians have found the clinical features of COVID-19 pneumonia to be similar to high-altitude pulmonary oedema (HAPE) [1], and such theory has been amplified via social media. We question this relationship.
引用
- Strapazzon G, Hilty MP, Bouzat P, et al. To compare the incomparable: COVID-19 pneumonia and high-altitude disease. Eur Respir J. 2020. PMID: 32398299. doi:10.1183/13993003.01362-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。